Senior Clinical Operations Asset Lead — Lung Oncology

GlaxoSmithKline; Philadelphia (Philadelphia County); On-site; USD 190,000 - 316,000; Full time

Benefits offered by this job

Health benefits

Retirement benefits

Paid holidays

Vacation

Parental leave

Job summary

GlaxoSmithKline in the United States seeks a Clinical Operations Asset Lead (COAL) for Late Phase Lung Oncology. You will translate scientific strategy into executable operational plans and serve as senior guardian of asset delivery across multiple studies and indications.

You will shape development plans, drive risk management, budget forecasting, and governance across Study Delivery Teams, with external partners and CRO oversight.

Qualifications

• Bachelor's degree in life sciences, healthcare, business or related field, or equivalent experience.
• Minimum of 10 years of pharmaceutical R&D or related industry experience.
• At least 3 years as COAL (or similar) in lung cancer indications
• 5+ years of experience managing global, complex programs with multiple studies
• Experience preparing for BLA filing and BLA inspection readiness
• Deep therapeutic area expertise in lung treatment landscape and competitive environment

Responsibilities

• Own the clinical operational strategy and end-to-end delivery of the asset
• Shape the Clinical Development Plan and Integrated Evidence Plan
• Lead asset-level operational planning and scenario modelling
• Define and oversee the asset resourcing strategy
• Provide strategic leadership across Study Delivery Teams
• Drive asset-level risk management, quality and inspection readiness
• Lead operational strategies across countries, patient engagement, diversity and study execution
• Ensure robust financial, data and stakeholder governance

Job description

GlaxoSmithKline in the United States seeks a Clinical Operations Asset Lead (COAL) for Late Phase Lung Oncology. You will translate scientific strategy into executable operational plans and serve as senior guardian of asset delivery across multiple studies and indications.

You will shape development plans, drive risk management, budget forecasting, and governance across Study Delivery Teams, with external partners and CRO oversight.